Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism
- PMID: 26377492
- DOI: 10.1007/s11255-015-1106-x
Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism
Abstract
Introduction: The life for end-stage renal disease patients has remarkably improved in the last years. Although mineral and bone disorders remain as unsolved complication, in severe secondary hyperparathyroidism (sHPT), the ultimate treatment is parathyroidectomy (PTX). It is an old treatment, but there are still insufficient data regarding survival after PTX. The study goals were to compare 2-year mortality and morbidity after PTX in surgically versus medically treated sHPT and to compare the efficacy and safety in subtotal versus total PTX in a cohort of patients receiving hemodialysis (HD).
Methods: This prospective, longitudinal study was carried out on a cohort of chronic HD patients with severe sHPT (iPTH over 700 pg/ml). Among the overall HD population, 26 patients underwent PTX. This group was compared to a control group treated with specific drugs. Laboratory parameters, specific symptoms and mortality were registered after 24 months of follow-up for each group. The subgroups of subtotal and total PTX patients were also compared.
Results: All average values of mineral markers were significantly reduced after PTX, as a proof that surgical treatment was effective. The reduction in mineral markers and the improvement in symptoms and mortality rates were similar after total and subtotal PTX. Bone pain was significantly lower in patients after PTX than in those drug treated (p = 0.0005), but not muscle weakness and itching. Survival at 2 years was better in patients surgically treated (PTX) despite significantly higher mean baseline values of iPTH, Ca and ALP compared to patients medically treated (p = 0.03).
Conclusions: We compared clinical and laboratory outcomes in HD patients with severe sHPT. Mortality, bone pain and mineral markers were improved by PTX. Total and subtotal PTX had similar clinical outcomes.
Keywords: Hemodialysis patients; Parathyroidectomy; Secondary hyperparathyroidism; Survival.
Similar articles
-
Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.Ren Fail. 2019 Nov;41(1):921-929. doi: 10.1080/0886022X.2019.1666724. Ren Fail. 2019. PMID: 31573378 Free PMC article.
-
[Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].Zhonghua Nei Ke Za Zhi. 2011 Jul;50(7):562-7. Zhonghua Nei Ke Za Zhi. 2011. PMID: 22041265 Chinese.
-
Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.Blood Purif. 2013;36(2):116-21. doi: 10.1159/000353415. Epub 2013 Nov 5. Blood Purif. 2013. PMID: 24217122
-
[Treatment of secondary and tertiary hyperparathyroidism--surgical viewpoints].Chirurg. 1999 Oct;70(10):1089-101. doi: 10.1007/s001040050870. Chirurg. 1999. PMID: 10550338 Review. German.
-
Long-term outcomes and management considerations after parathyroidectomy in the dialysis patient.Semin Dial. 2019 Nov;32(6):541-552. doi: 10.1111/sdi.12833. Epub 2019 Jul 16. Semin Dial. 2019. PMID: 31313380 Review.
Cited by
-
Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism.J Int Med Res. 2020 Jan;48(1):300060519897505. doi: 10.1177/0300060519897505. J Int Med Res. 2020. PMID: 31948313 Free PMC article.
-
Effect of calcium supplementation on severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy.World J Clin Cases. 2022 May 6;10(13):4033-4041. doi: 10.12998/wjcc.v10.i13.4033. World J Clin Cases. 2022. PMID: 35665128 Free PMC article.
-
Can we predict who will develop postoperative hyperkalaemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism?BMC Nephrol. 2019 Jun 20;20(1):225. doi: 10.1186/s12882-019-1416-9. BMC Nephrol. 2019. PMID: 31221111 Free PMC article.
-
Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - A systematic review and meta-analysis.PLoS One. 2017 Nov 6;12(11):e0187025. doi: 10.1371/journal.pone.0187025. eCollection 2017. PLoS One. 2017. PMID: 29107998 Free PMC article.
-
Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.Sci Rep. 2018 May 17;8(1):7743. doi: 10.1038/s41598-018-26142-9. Sci Rep. 2018. PMID: 29773914 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical